Lower Extremity Peripheral Arterial Disease: Its All About the Pulse. Spence M Taylor, M.D.

Size: px
Start display at page:

Download "Lower Extremity Peripheral Arterial Disease: Its All About the Pulse. Spence M Taylor, M.D."

Transcription

1 Lower Extremity Peripheral Arterial Disease: Its All About the Pulse Spence M Taylor, M.D. President, Greenville Health System Clinical University Senior Associate Dean for Academic Affairs and Diversity University of South Carolina School of Medicine Greenville April 28- May 1, 2016 G H S C l i n i c a l U n i v e r s i t y P a r t n e r s

2 Lower Extremity Peripheral Artery Disease Disclosure Statement World according to Spence Taylor Expert Opinion

3 Critical Limb Ischemia Management 2016 Case Presentation

4 Case Presentation 60yo diabetic presents w/ CLI Sent for A-gram

5 Case Presentation ABI from 0.3 to 0.8 (ankle pressure 90) Discharged home with f/u in clinic-one week With good blood flow, he will do well Comes to the ER at 10 days with a pulse and gas extending to the ankle

6 Lessons Learned Its All About the Pulse G H S C l i n i c a l U n i v e r s i t y P a r t n e r s

7 Wilford Hall USAF Medical Center Greenville Health System Greenville SC

8 Spence Taylor MD & the STS 1992

9 Factors associated with limb loss despite a patent infrainguinal bypass graft. Carsten CG, Taylor SM, Langan EM, Crane MM Am Surg Jan;64(1):33-7 Lower-extremity limb salvage should parallel infrainguinal bypass graft patency. To determine factors associated with limb loss despite a patent bypass, we reviewed 191 consecutive infrainguinal bypasses in 158 patients followed prospectively over 42 months. In this series 191 of Bypasses/ (92%) vein grafts, patients 15 (8%) expanded polytetrafluoroethylene grafts, 122 (64%) tibial artery bypasses, and 170 (89%) bypasses placed for limb salvage, 29 major lower-extremity (above-knee or below-knee) amputations were Mean performed f/u 42 in 29 months patients, 12 because of ischemia after graft thrombosis and 1729 (9% amputations of series) due to progression (17 [9% of soft total tissue series] infection/necrosis w/ patent despite bypass) a functioning bypass. Primary and secondary 36-month vein graft patencies by life-table analysis were 61 per cent and 81 per cent, respectively. When the 17 cases of limb loss were compared to the rest of the series, nonstatistically significant CKD, Diabetic neuropathic ulcers: independent predictors variables included male sex [11 (65%) vs 79 (56%); P = 0.608] and diabetes [12 (71%) vs 80 (57%); P = 0.310]. Statistically significant variables included black race [9 (53%) vs 39 (28%); P = 0.048]; chronic renal failure [6 (35%) vs 12 (9%); P = 0.005], placement to a tibial/pedal artery [15 (88%) vs 107 (62%); P = 0.034], distal anastomosis to the anterior tibial/dorsalis pedis (AT/DP) artery [8 (47%) vs 27 (16%); P = 0.004], and grafts requiring late revision [7 (41%) vs 22 (13%); P = 0.006]. Thirteen (76%) extremities had an intact pedal arch. Nine amputations were performed within 30 days (early group), and eight were performed from 45 days to 20 months

10 It s not about the pulse: More Cull DL, et al. Open versus Endovascular Intervention for Critical Limb Ischemia: A Population-Based Study. J Am Col Surg 2010;210(5):555-63

11 An Assessment Cull DL, et al: SSA 2009 Open Era 1996 n=570 30% Endo Era 2005 n=749 Open/ Endo 75%/25% 50%/50% 1) # of 2 revascularizations doubled (8%-19%) 2) Amputation rate not improved ~ 3years

12 An Assessment Cull DL, et al: SSA 2009 Our shift from open surgery to endovascular, while less invasive, has increased the amount of care without improving outcomes It s not just about endovascular revascularization: There is more

13 Other Lessons Limb salvage is like cancer; complex, multifactorial (not just vascular), prognostically challenging and needs a multidisciplinary approach A standardized treatment approach is needed A standardized diagnostic terminology is needed Precision Medicine: Patient centered outcomes

14 If CLI is like cancer: Multidisciplinary treatment standardization..what is our appetite?

15 Our Observation & a Plan: Seems we get confused about how and when to treat people with PAD. Some perform open surgery for certain problems while others perform angioplasty. Some do nothing. Lets decide to put together a treatment algorithm to help direct how best to treat PAD given various clinical presentations. What do you think? Peter Mackrell MD 1999

16 Its 1999, why do we need to standardize and where is the confusion?

17 Type of Care Rendered? Toyota Corolla Care

18 Peripheral Angioplasty Less invasive Better tolerated Less durable Anatomy/Other: Short lesions Big diameter Good R/O Higher risk pts Open Bypass More invasive Less well tolerated More durable Anatomy/Other: Long lesions More ischemia Good risk pts Diabetics

19 The Lower Extremity Grading System (LEGS) Score Arteriographic Findings Presentation Functional Status Co-morbidities Technical Factors - Aortic - Claudication 5 - Ambulatory 0 - Obesity 2 All Cases < 3 cm aortic stenosis/ - Redo surgery 2 occlusion or 3-5 cm stenosis - Limb threatening - Ambulatory/ - High risk coronary of aorto-iliac bifurcation 8 ischemia 2 at home only 2 artery disease 3 - Redo angioplasty -2 > 3 cm aortic stenosis/ occlusion or > 5 cm stenosis - Non-ambulatory/ - Age Infrainguinal Cases of aorto-iliac bifurcation 0 transfer only 5 > Blind segment target 2 - Iliac - Non-ambulatory 20 > 80 2 TASC A or B 8 - No venous TASC C 2 conduit 6 TASC D 0 or - No vein w/ foot - Fem-pop-tib infection 8 < 5 cm occlusion/stenosis 5 > 5 cm occlusion w/ distal target 0 Isolated common/deep femoral stenosis 0 Possible score: 2-5 Possible score: 0-20 Possible score: 0-7 Possible score: > 5 cm occlusion w/o distal target 6 Recommended Treatment: (sum of total score from each column) * If a heel ulcer and ESRD -0 9 = open surgery are present, double the score Possible score: = endovascular ->20 = primary amputation

20

21 Case Like Control a Lead Study Balloon 100pts LEGS v 100pts Contrary *LEGS better outcomes@ 6mos -Patency -Limb salvage -Ambulation We will figure it out as we learn more about endovascular

22 What more can we really learn? Twenty-Year Med Pub Search Endovascular intervention: 32,182 citations Open bypass: 5,369 citations Open bypass vs. Endovascular: 57citations We have looked at the elephant..from about every angle

23 The Oculostenotic Reflex

24 Multidisciplinary treatment standardization..we have a ways to go

25 Glimmers of hope Southern Arizona Limb Salvage Alliance (SALSA)

26 If PAD is like cancer: Standardized Terminology

27 The term CLI lacks specificity

28 Factors influencing amputation risk

29 The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI) Mills JL, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, Andros G on behalf the Society for Vascular Surgery Lower Extremity Guidelines Committee J Vasc Surg Jan;59(1):

30 WIfI Clinical Stage Ischemia - 0 Ischemia - 1 Ischemia - 2 Ischemia - 3 W-0 VL VL L M VL L M H L L M H L M M H W-1 VL VL L M VL L M H L M H H M M H H W-2 L L M H M M H H M H H H H H H H W-3 M M H H H H H H H H H H H H H H fi-0 fi-1 fi-2 fi-3 fi-0 fi-1 fi-2 fi-3 fi-0 fi-1 fi-2 fi-3 fi-0 fi-1 fi-2 fi-3 WIfI Clinical Stage Amputation Risk at 1 year 1 Very Low (3%) 2 Low (8%) 3 Moderate (25%) 4 High (50%)

31 SVS WIFI CLASSIFICATION GRADE WOUND ISCHEMIA FOOT INFECTION ULCER GANGRENE ABI TP INFECTION 0 None None >0.8 > 60 mm Hg None 1 Shallow None mm Hg Mild 2 Deep Digits only mm Hg Moderate 3 Extensive Extensive <0.39 < 30 mm Hg Severe (SIR) The WIfI classification system grades each factor on a severity scale from 0 to 3. The original document outlines each grade in much greater detail; the basic delineations for each factor are shown above with respect to unaffected, mild, moderate, and severe wound, ischemia, and foot infection grades.

32 Critical Limb Ischemia : Too Simple We need to devise a foot ischemia classification that takes into consideration the degree of foot wound Infection David L Cull M.D

33 Comparison of GCLI and WIfI Grades Greenville CLI Grades Wound Diameter Grade 1 3 Depth Grade 1 3 Type Ulcer/gangrene Location Grade 1 3 Ischemia Grade 1 3 Infection Grade 1-4 WIfI Grades Wound Grade 0 3 Ischemia Grade 0 3 Infection Grade 0-3

34 Prospective Analysis of Wound Characteristics, Degree of Ischemia, and Extent of Infection on Time to Wound Healing and Limb Salvage: An Early Validation of the SVS Lower Extremity Threatened Limb Classification System David L. Cull, MD Ginger Manos, MD Michael C. Hartley, MD Spence M. Taylor, MD Eugene M. Langan, MD John F. Eidt, MD Brent L. Johnson, MS G H S C l i n i c a l U n i v e r s i t y P a r t n e r s

35 Purpose To determine whether the WIfI clinical stage risk stratification estimated by the SVS expert panel compares to actual patient outcomes. To determine whether the WIfI clinical stage is predictive of wound healing.

36 Methods Jan 2008 Dec 2010 patients with a foot wound + revascularization procedure At the intervention the wound/infection grades were assigned by a vascular attending or resident Ischemia grade was assigned after the procedure

37 Results 139 patients/151 limbs/158 index wounds Males- 63% Mean age- 70 yrs Tobacco use- 66% Comorbidities Diabetes mellitus 65% Coronary artery disease 64% End stage renal disease 15%

38 139 patients/151 limbs/158 index wounds WIfI Clinical Stage Predicted Observed Observed Amputation Amputation Non-Healing Stage 1 (n= 40) 3% 3% 8% Stage 2 (n= 64) 8% 10% 19% Stage 3 (n= 46) 25% 23% 30% Stage 4 (n= 8) 50% 40% 63%

39 139 patients/151 limbs/158 index wounds Wound Healing OR Amputation OR (95% CI) (95% CI) WIfI Stage (Referent) 1.00 (Referent) WIfI Stage 2.29 ( ) 4.8 ( ) WIfI Stage 3.15 ( ) 10.8 ( ) WIfI Stage 4.05 ( ) 23.4 ( )

40 Factors Associated with Wound Healing Bivariate Analysis Smoking (p=0.03) Wound size (p=0.004) Wound depth (p=0.001) Ischemia grade (p<0.001) Factors Associated with Limb Amputation Bivariate Analysis Smoking (p=0.027) Wound size (p=0.026) Ischemia grade (p<0.001) Infection grade (p=0.05) Multivariate Analysis Ischemic grade Infection grade Multivariate Analysis Ischemia grade Infection grade Diabetes mellitus 40

41 Conclusions: WIfI promises not only to serve as a tool for comparing treatment modalities but also as a clinical decisionmaking tool to guide treatment

42 Risk of amputation versus SVS WIfI Stage: Compilation of published data Study (year): # limbs at risk Stage 1 Stage 2 Stage 3 Stage 4 Cull (2014): (3%) 63 (10%) 43 (23%) 8 (40%) Zhan (2015): (0%) 50 (0%) 53 (8%) 59 (37%) Darling (2015): (0%) 111 (2%) 222 (6%) 213 (28%) Causey (2016): (0%) 48 (25%) 42 (21%) 49 (31%) Beropoulis (2016): (13%) 42 (19%) 29 (19%) 26 (38%) N = 1189 (weighted average) 131 (4% ) 314 ( 9%) 389 (11%) 355 (31%) Number of limbs at risk in each WIfI Stage with % amputation at 1 year in parentheses Averages in total in bottom row (in parentheses) are weighted

43 If PAD is like cancer: What about precision therapy targeted at each patient? Doctor Knows Best

44 Patient Centered Outcomes: What Does the Patient Want from Intervention? Analysis of 102 Patients; Elective Surgery 66% based decision on surgeon recommendation Success: No need to return to doctor -82% Maintenance of daily activity -65% Maintenance of mobility -61% Relief/avoidance pain -58% Continue hobbies -54% Continue work -12%

45 A Definition of Success Success after Revascularization for CLI According to the Patient All of the following: 1. Maintenance of living independence 2. Maintenance of ambulatory status 3. Control/relief of pain 4. No additional/non-routine physician visits 5. Survival for one year

46 Patient-Centered Outcome of Success Tested on 954 patients Successful Outcome 218/954 combining (23%) all components: Independent Predictors of Failure ESRD (OR 2.21; p=0.006) Impaired ambulation (OR 1.76; p=0.015)

47 A Resident s Observation: The residents, get confused about how and when to treat people with PAD. Some attendings perform open surgery for certain problems while others perform angioplasty. Some do nothing. We have decided to put together a treatment algorithm to help direct how best to treat PAD given various clinical presentations. What do you think? Taylor SM, et al. The LEGS Score: A proposed grading system to direct treatment of chronic lower extremity ischemia. Ann Surg; 2003:

48 Expert Opinion According to Spence Taylor It s not just about the pulse Vascular disease of the lower extremities is as deadly as cancer, why not stage it and treat it like cancer in a multidisciplinary fashion? Let s benchmark and standardize care like the oncologists; Should be easy Right? Maybe Doctor does not know best

49

Chronic lower Extremity Peripheral Arterial Disease: The Relentless Pursuit of Mediocrity

Chronic lower Extremity Peripheral Arterial Disease: The Relentless Pursuit of Mediocrity Chronic lower Extremity Peripheral Arterial Disease: The Relentless Pursuit of Mediocrity Spence M Taylor, MD Assistant Dean for Academic Affairs Greenville Hospital System University Medical Center, Chairman

More information

Lower Extremity Peripheral Arterial Disease: Less is Sometimes More. Spence M Taylor, M.D.

Lower Extremity Peripheral Arterial Disease: Less is Sometimes More. Spence M Taylor, M.D. Lower Extremity Peripheral Arterial Disease: Less is Sometimes More Spence M Taylor, M.D. President, Greenville Health System Clinical University Senior Associate Dean for Academic Affairs and Diversity

More information

LIMB SALVAGE IN THE DIABETIC PATIENT

LIMB SALVAGE IN THE DIABETIC PATIENT LIMB SALVAGE IN THE DIABETIC PATIENT WHO? HOW? BEST? DISCLOSURES Educational grant from Cook Inc OBJECTIVES Review risk stratification and staging schemes for the threatened limb Discuss current concepts

More information

Global Vascular Guideline on the Management of Chronic Limb Threatening Ischemia -a new foundation for evidence-based care

Global Vascular Guideline on the Management of Chronic Limb Threatening Ischemia -a new foundation for evidence-based care Global Vascular Guideline on the Management of Chronic Limb Threatening Ischemia -a new foundation for evidence-based care Michael S. Conte MD Professor and Chief, Division of Vascular and Endovascular

More information

GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE

GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE Michael S. Conte MD Professor and Chief, Vascular and Endovascular Surgery Co-Director, Center for Limb Preservation Co-Director, Heart and Vascular

More information

Clasificación WIFI: Finalmente hablaremos el mismo idioma! WIfI: Wound, Ischemia, foot Infection The SVS Threatened Limb Classification

Clasificación WIFI: Finalmente hablaremos el mismo idioma! WIfI: Wound, Ischemia, foot Infection The SVS Threatened Limb Classification Clasificación WIFI: Finalmente hablaremos el mismo idioma! WIfI: Wound, Ischemia, foot Infection The SVS Threatened Limb Classification Joseph L. Mills, Sr., M.D. Professor of Surgery, Chief, Vascular

More information

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI? Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI? Peter F. Lawrence, M.D. Gonda Vascular Center Division of Vascular Surgery

More information

Acknowledgements. No tengo conflictos de interés que revelar. I have no conflicts of interest to disclose. Michael S. Conte. David G.

Acknowledgements. No tengo conflictos de interés que revelar. I have no conflicts of interest to disclose. Michael S. Conte. David G. No tengo conflictos de interés que revelar I have no conflicts of interest to disclose. Critical Limb Ischemia : The Need for a New System to Define Disease Burden and Stratify Amputation Risk and Need

More information

Endovascular Should Be Considered First Line Therapy

Endovascular Should Be Considered First Line Therapy Revascularization of Patients with Critical Limb Ischemia Endovascular Should Be Considered First Line Therapy Michael Conte David Dawson David L. Dawson, MD Revised Presentation Title A Selective Approach

More information

Imaging Strategy For Claudication

Imaging Strategy For Claudication Who are the Debators? Imaging Strategy For Claudication Duplex Ultrasound Alone is Adequate to Select Patients for Endovascular Intervention - Pro: Dennis Bandyk MD No Disclosures PRO - Vascular Surgeon

More information

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are An initial strategy of open bypass is better for some CLI patients, and we can define who they are Fadi Saab, MD, FASE, FACC, FSCAI Metro Heart & Vascular Metro Health Hospital, Wyoming, MI Assistant Clinical

More information

Case Discussion. Disclosures. Critical Limb Ischemia: A Selective Approach to Revascularization Works Best 4/28/2012. None. 58 yo M, DM, CAD, HTN

Case Discussion. Disclosures. Critical Limb Ischemia: A Selective Approach to Revascularization Works Best 4/28/2012. None. 58 yo M, DM, CAD, HTN Critical Limb Ischemia: A Selective Approach to Revascularization Works Best None Disclosures Michael S. Conte MD, FACS Division of Vascular and Endovascular Surgery Co-Director, Heart and Vascular Center

More information

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,

More information

Current Vascular and Endovascular Management in Diabetic Vasculopathy

Current Vascular and Endovascular Management in Diabetic Vasculopathy Current Vascular and Endovascular Management in Diabetic Vasculopathy Yang-Jin Park Associate professor Vascular Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine Peripheral artery

More information

Interventional Treatment First for CLI

Interventional Treatment First for CLI Interventional Treatment First for CLI Patrick Alexander, MD, FACC, FSCAI Interventional Cardiology Medical Director, Critical Limb Clinic Providence Heart Institute, Southfield MI 48075 Disclosures Consultant

More information

Making the difference with Live Image Guidance

Making the difference with Live Image Guidance Live Image Guidance 2D Perfusion Making the difference with Live Image Guidance In Peripheral Arterial Disease Real-time results, instant assessment Severe foot complications the result of hampered blood

More information

Limb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017

Limb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017 Limb Salvage in Diabetic Ischemic Foot Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017 Case Male 67 years old Underlying DM, HTN, TVD Present with gangrene

More information

Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia

Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia Albeir Mousa, MD., FACS.,MPH., MBA Professor of Vascular and Endovascular Surgery West Virginia University Disclosure None What you

More information

Peripheral arterial disease for primary care Ed Aboian, MD

Peripheral arterial disease for primary care Ed Aboian, MD Peripheral arterial disease for primary care Ed Aboian, MD Division of Vascular and Endovascular Surgery Palo Alto Medical Foundation, Burlingame Ca Disclosures Nothing to disclose Clinical presentation

More information

Practical Point in Diabetic Foot Care 3-4 July 2017

Practical Point in Diabetic Foot Care 3-4 July 2017 Diabetic Foot Ulcer : Role of Vascular Surgeon Practical Point in Diabetic Foot Care 3-4 July 2017 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai University

More information

Validation and Clinical Utility of the SVS WIfI Threatened Limb Classification

Validation and Clinical Utility of the SVS WIfI Threatened Limb Classification Validation and Clinical Utility of the SVS WIfI Threatened Limb Classification PRESENTED BY: 11 th Houston Aortic Symposium 15 February 2018 Joseph L. Mills, Sr., M.D. Reid Endowed Professor of Surgery

More information

Critical Limb Ischemia A Collaborative Approach to Patient Care. Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017

Critical Limb Ischemia A Collaborative Approach to Patient Care. Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017 Critical Limb Ischemia A Collaborative Approach to Patient Care Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017 Surgeons idea Surgeons idea represents the final stage of peripheral

More information

Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia

Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia Traci A. Kimball, MD Department of Surgery Grand Rounds Septemember 13, 2010 Overview Defining Critical Limb Ischemia Epidemiology

More information

Practical Point in Holistic Diabetic Foot Care 3 March 2016

Practical Point in Holistic Diabetic Foot Care 3 March 2016 Diabetic Foot Ulcer : Vascular Management Practical Point in Holistic Diabetic Foot Care 3 March 2016 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai

More information

Easy. Not so Easy. Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? 4/28/2012

Easy. Not so Easy. Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? 4/28/2012 Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? Easy 89 yo Non-ambulatory Multiple failed interventions Forefoot and heel gangrene Andres Schanzer, MD

More information

9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge

9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge Disclosures State-of-the-Art Endovascular Lower Extremity Revascularization Promotional Speaker Jansen Pharmaceutical Promotional Speaker Amgen Pharmaceutical C. Michael Brown, MD, FACC al Cardiology Associate

More information

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio The present status of selfexpanding and balloonexpandable tibial BMS and DES for CLI: Why and when to use Sean P Lyden MD Cleveland Clinic Cleveland, Ohio Disclosure Speaker name: Sean Lyden, MD I have

More information

3-year results of the OLIVE registry:

3-year results of the OLIVE registry: 3-year results of the OLIVE registry: A prospective multicenter study in patients with critical limb ischemia Osamu Iida, MD Kansai Rosai Hospital Cardiovascular Center Amagasaki, Hyogo, Japan Disclosure

More information

Pedal Bypass With Deep Venous Arterialization:

Pedal Bypass With Deep Venous Arterialization: Pedal Bypass With Deep Venous Arterialization: Long Term Result For Critical Limb Ischemia With Unreconstructable Distal Arteries Pramook Mutirangura Professor of Vascular Surgery Faculty of Medicine Siriraj

More information

4/23/2009. Vein Bypass Remains the Gold Standard AND We Can Improve Outcomes. Lower Extremity Revascularization Options: Key Factors to Consider

4/23/2009. Vein Bypass Remains the Gold Standard AND We Can Improve Outcomes. Lower Extremity Revascularization Options: Key Factors to Consider Vein Bypass Remains the Gold Standard AND We Can Improve Outcomes Lower Extremity Revascularization Options: Key Factors to Consider General health of the patient Michael S. Conte MD Division of Vascular

More information

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview Tips and Tricks for Tibial Intervention Donald L. Jacobs, MD C Rollins Hanlon Endowed Professor and Chair Chair of Surgery Saint Louis University SSM-STL Saint Louis University Hospital Disclosures Abbott

More information

The SVS WIfI Classification: Does It Predict Amputation in Diabetic Patients?

The SVS WIfI Classification: Does It Predict Amputation in Diabetic Patients? The SVS WIfI Classification: Does It Predict Amputation in Diabetic Patients? Christopher J. Abularrage, MD, FACS The Bertram M. Bernheim Associate Professor of Surgery Division of Vascular Surgery and

More information

Disclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention

Disclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention In-Stent Restenosis: The Tail IS Wagging the Dog Disclosures NONE Michael S. Conte MD Division of Vascular and Endovascular Surgery UCSF Heart and Vascular Center UCSF Vascular Symposium 2016 IF YOU WERE

More information

Surgical Options for revascularisation P E T E R S U B R A M A N I A M

Surgical Options for revascularisation P E T E R S U B R A M A N I A M Surgical Options for revascularisation P E T E R S U B R A M A N I A M The goal Treat pain Heal ulcer Preserve limb Preserve life The options Conservative Endovascular Surgical bypass Primary amputation

More information

Evidence-Based Optimal Treatment for SFA Disease

Evidence-Based Optimal Treatment for SFA Disease Evidence-Based Optimal Treatment for SFA Disease Endo first Don t burn surgical bridge Don t stent if possible Javairiah Fatima, MD Assistant Professor of Surgery Division of Vascular and Endovascular

More information

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Step by step Hybrid procedures in peripheral obstructive disease Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Disclosure Speaker name: H.H. Staab I have the following

More information

Managing Conditions Resulting from Untreated Cardiometabolic Syndrome

Managing Conditions Resulting from Untreated Cardiometabolic Syndrome Managing Conditions Resulting from Untreated Cardiometabolic Syndrome Matthew P. Namanny DO, FACOS Vascular/Endovascular Surgery Saguaro Surgical/AZ Vascular Specialist Tucson Medical Center Critical Limb

More information

SPINACH Making Limb Salvage Salad from Spinach alone

SPINACH Making Limb Salvage Salad from Spinach alone SPINACH Making Limb Salvage Salad from Spinach alone Surgical reconstruction versus Peripheral Intervention in patients with critical limb ischemia prospective multicenter registry in Japan Nobuyoshi Azuma,

More information

Peripheral Vascular Disease

Peripheral Vascular Disease Peripheral artery disease (PAD) results from the buildup of plaque (atherosclerosis) in the arteries of the legs. For people with PAD, symptoms may be mild, requiring no treatment except modification of

More information

EVALUATION OF THE VASCULAR STATUS OF DIABETIC WOUNDS Travis Littman, MD NorthWest Surgical Specialists

EVALUATION OF THE VASCULAR STATUS OF DIABETIC WOUNDS Travis Littman, MD NorthWest Surgical Specialists EVALUATION OF THE VASCULAR STATUS OF DIABETIC WOUNDS Travis Littman, MD NorthWest Surgical Specialists Nothing To Disclosure DISCLOSURES I have no outside conflicts of interest, financial incentives, or

More information

Disclosures. Objectives. Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach. Christopher D. Owens, MD 4/23/2009

Disclosures. Objectives. Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach. Christopher D. Owens, MD 4/23/2009 Disclosures Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach No disclosures No conflicts of interest Christopher D. Owens, MD Objectives Changing face of our patients presenting

More information

Peripheral Artery Disease Interventions Utilizing the Angiosomal Approach to the Complex Wound

Peripheral Artery Disease Interventions Utilizing the Angiosomal Approach to the Complex Wound Peripheral Artery Disease Interventions Utilizing the Angiosomal Approach to the Complex Wound Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine Tulane

More information

Will it heal? How to assess the probability of wound healing

Will it heal? How to assess the probability of wound healing Will it heal? How to assess the probability of wound healing Richard F. Neville, M.D. Professor of Surgery Chief, Division of Vascular Surgery George Washington University Limb center case 69 yr old male

More information

Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC

Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Interventional Cardiologist/Endovascular Specialist Bradenton Cardiology Center Bradenton,

More information

CRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS

CRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS CRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS CRITICAL LIMB ISCHEMIA... 1 CONCLUSION... 9 U.S. CRITICAL LIMB ISCHEMIA PREVALENCE... 9 MARKET OPPORTUNITY ENDOVASCULAR... 9 MARKET OPPORTUNITY

More information

Angiosome concept myth or truth? Does it make a real difference in real world cases?

Angiosome concept myth or truth? Does it make a real difference in real world cases? Angiosome concept myth or truth? Does it make a real difference in real world cases? Osamu Iida, MD, FACC Kansai Rosai Hospital Amagasaki, Hyogo, Japan Disclosure Speaker name:... I have the following

More information

4/14/2016. How Far Should We Go with the Endovascular Treatment of Advanced PAD in the Era of Health Care Reform?

4/14/2016. How Far Should We Go with the Endovascular Treatment of Advanced PAD in the Era of Health Care Reform? FINANCIAL DISCLOSURE How Far Should We Go with the Endovascular Treatment of Advanced PAD in the Era of Health Care Reform? An Endocompetent Vascular Surgeon s View Bruce A. Perler, MD, MBA I Have No Financial

More information

PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014

PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014 PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014 Van Crisco, MD, FACC, FSCAI First Coast Heart and Vascular Center, PLLC Jacksonville, FL 678-313-6695 Conflict of Interest Bayer Healthcare

More information

Angiosome revascularization strategies in real world practice: how much difference does it make?

Angiosome revascularization strategies in real world practice: how much difference does it make? Angiosome revascularization strategies in real world practice: how much difference does it make? Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii Disclosure Peter A. Schneider... I have

More information

Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease

Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease Arash Bornak, MD FACS Vascular & Endovascular Surgery University of Miami Miller School of Medicine No disclosure BACKGROUND

More information

BEST-CLI Trial Study Concept and Current Status

BEST-CLI Trial Study Concept and Current Status BEST-CLI Trial Study Concept and Current Status Kenneth Rosenfield, MD, MHCDS National Co-PI BEST-CLI Trial Section Head, Vascular Medicine and Intervention Institute for Heart, Vascular, and Stroke Care

More information

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE Disclosure Speaker name: DR. Manar Trab I have the following potential

More information

Endovascular Is The Way To Go: Revascularize As Many Vessels As You Can

Endovascular Is The Way To Go: Revascularize As Many Vessels As You Can Rafael Malgor, MD Assistant Professor of Surgery The University of Oklahoma, Tulsa Endovascular Is The Way To Go: Revascularize As Many Vessels As You Can Background Lower extremity anatomy (below the

More information

Peripheral Arterial Disease: A Practical Approach

Peripheral Arterial Disease: A Practical Approach Peripheral Arterial Disease: A Practical Approach Sanjoy Kundu BSc, MD, FRCPC, DABR, FASA, FCIRSE, FSIR The Scarborough Hospital Toronto Endovascular Centre The Vein Institute of Toronto Scarborough Vascular

More information

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step -

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step - Hybrid Procedures for Peripheral Obstructive Disease - Step by Step - Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Disclosure Speaker name:..holger Staab... I have

More information

Multidisciplinary approach to BTK Y. Gouëffic, MD, PhD

Multidisciplinary approach to BTK Y. Gouëffic, MD, PhD Multidisciplinary approach to BTK Y. Gouëffic, MD, PhD Department of vascular surgery, University Hospital of Nantes, France Response to the increased demand of hospital care Population is aging Diabetes

More information

Do the newest grafts achieve comparable results to saphenous vein bypass? THE HEPARIN-BONDED eptfe GRAFT. C. Pratesi

Do the newest grafts achieve comparable results to saphenous vein bypass? THE HEPARIN-BONDED eptfe GRAFT. C. Pratesi Do the newest grafts achieve comparable results to saphenous vein bypass? THE HEPARIN-BONDED eptfe GRAFT C. Pratesi Department of Vascular Surgery University of Florence-Italy www.chirvasc-unifi.it FEMORO-POPLITEAL

More information

Invasive treatment of chronic limb ischemia according to the Lower Extremity Grading System (LEGS) score: A 6-month report

Invasive treatment of chronic limb ischemia according to the Lower Extremity Grading System (LEGS) score: A 6-month report From the Southern Association for Vascular Surgery Invasive treatment of chronic limb ischemia according to the Lower Extremity Grading System (LEGS) score: A 6-month report Corey A. Kalbaugh, MS, a Spence

More information

Objective assessment of CLI patients Hemodynamic parameters

Objective assessment of CLI patients Hemodynamic parameters Objective assessment of CLI patients Hemodynamic parameters Worth anything in end stage patients? Marianne Brodmann Angiology, Medical University Graz, Austria Disclosure Speaker name: Marianne Brodmann

More information

VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS

VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS KANSAS ASSOCIATION OF OSTEOPATHIC MEDICINE ANNUAL CME CONVENTION APRIL 13, 2018 THREE

More information

Current Status of Endovascular Therapies for Critical Limb Ischemia

Current Status of Endovascular Therapies for Critical Limb Ischemia Current Status of Endovascular Therapies for Critical Limb Ischemia Bulent Arslan, MD Associate Professor of Radiology Director, Vascular & Interventional Radiology Rush University Medical Center bulent_arslan@rush.edu

More information

Wifi classification does not predict limb amputation risk in dialysis patients following critical limb ischemia revascularization

Wifi classification does not predict limb amputation risk in dialysis patients following critical limb ischemia revascularization Wifi classification does not predict limb amputation risk in dialysis patients following critical limb ischemia revascularization A Sonetto, M Abualhin, M Gargiulo, GL Faggioli, A Stella Disclosure Speaker

More information

Intercepting PAD. Playbook for Cardiovascular Care 2018 February 24, Jonathan D Woody, MD, FACS. University Surgical Vascular

Intercepting PAD. Playbook for Cardiovascular Care 2018 February 24, Jonathan D Woody, MD, FACS. University Surgical Vascular Intercepting PAD Playbook for Cardiovascular Care 2018 February 24, 2018 Jonathan D Woody, MD, FACS University Surgical Vascular Attending Vascular Surgeon - Piedmont Athens Regional Adjunct Clinical Associate

More information

Disclosures. Critical Limb Ischemia. Vascular Testing in the CLI Patient. Vascular Testing in Critical Limb Ischemia UCSF Vascular Symposium

Disclosures. Critical Limb Ischemia. Vascular Testing in the CLI Patient. Vascular Testing in Critical Limb Ischemia UCSF Vascular Symposium Disclosures Vascular Testing in the CLI Patient None 2015 UCSF Vascular Symposium Warren Gasper, MD Assistant Professor of Surgery UCSF Division of Vascular Surgery Critical Limb Ischemia Chronic Limb

More information

Perfusion Assessment in Chronic Wounds

Perfusion Assessment in Chronic Wounds Perfusion Assessment in Chronic Wounds American Society of Podiatric Surgeons Surgical Conference September 22, 2018 Michael Maier, DPM, FACCWS Cardiovascular Medicine Cleveland Clinic Disclosures Speaker,

More information

Olive registry: 3-years outcome of BTK intervention in Japan. Osamu Iida, MD Kansai Rosai Hospital Amagasaki, Hyogo, Japan

Olive registry: 3-years outcome of BTK intervention in Japan. Osamu Iida, MD Kansai Rosai Hospital Amagasaki, Hyogo, Japan Olive registry: 3-years outcome of BTK intervention in Japan Osamu Iida, MD Kansai Rosai Hospital Amagasaki, Hyogo, Japan What is the optimal treatment for the patient with critical limb ischemia (CLI)?

More information

Peripheral Arterial Disease: Who has it and what to do about it?

Peripheral Arterial Disease: Who has it and what to do about it? Peripheral Arterial Disease: Who has it and what to do about it? Seth Krauss, M.D. Alaska Annual Nurse Practitioner Conference September 16, 2011 Scope of the Problem Incidence: 20%

More information

Ron Fairman, MD Vice-President of the Society for Vascular Surgery MedCAC 2015

Ron Fairman, MD Vice-President of the Society for Vascular Surgery MedCAC 2015 Ron Fairman, MD Vice-President of the Society for Vascular Surgery MedCAC 2015 Ron Fairman, MD No Disclosures The SVS represents more than 5,000 practicing vascular surgeons across the US. The nation s

More information

FOR THE 18 MILLION INDIVIDUALS with diabetes mellitus in

FOR THE 18 MILLION INDIVIDUALS with diabetes mellitus in 11 Evaluation and Management of Peripheral Arterial Disease Joseph L. Mills, Sr., MD FOR THE 18 MILLION INDIVIDUALS with diabetes mellitus in the United States, foot problems ulceration, infection, and

More information

Fluorescent Angiography: Practical uses in the Clinical Setting

Fluorescent Angiography: Practical uses in the Clinical Setting Fluorescent Angiography: Practical uses in the Clinical Setting Charles Andersen MD, FACS, MAPWCA Chief Vascular/Endovascular/ Limb Preservation Surgery Service (Emeritus) Chief of Wound Care Service Madigan

More information

Vascular Surgery Cases: Detours. Brian F. Stull, RDMS, RVT UNC REX Healthcare Vascular Specialists

Vascular Surgery Cases: Detours. Brian F. Stull, RDMS, RVT UNC REX Healthcare Vascular Specialists Vascular Surgery Cases: Detours Brian F. Stull, RDMS, RVT UNC REX Healthcare Vascular Specialists Brian.Stull@Unchealth.unc.edu Objectives Anatomy of a bypass graft Where does it connect, where does it

More information

A Case for Mandatory Routine Graft Surveillance of lower extremity bypass grafts. Avishai Meyer UCHSC resident, Surgery May 8, 2006

A Case for Mandatory Routine Graft Surveillance of lower extremity bypass grafts. Avishai Meyer UCHSC resident, Surgery May 8, 2006 A Case for Mandatory Routine Graft Surveillance of lower extremity bypass grafts Avishai Meyer UCHSC resident, Surgery May 8, 2006 Outline: Definition Background of terms and studies U/S surveillance What

More information

Recommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines

Recommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines Recommendations for Follow-up After Vascular Surgery Arterial Procedures 2018 SVS Practice Guidelines vsweb.org/svsguidelines About the guidelines Published in the July 2018 issue of Journal of Vascular

More information

Introduction. Risk factors of PVD 5/8/2017

Introduction. Risk factors of PVD 5/8/2017 PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental

More information

Amputation as a Last Resort A Multidisciplinary Approach to Limb Salvage

Amputation as a Last Resort A Multidisciplinary Approach to Limb Salvage Amputation as a Last Resort A Multidisciplinary Approach to Limb Salvage George L. Adams, MD, MHS, MBA, FACC, FSCAI Clinical Associate Professor of Medicine University of North Carolina Health System Director

More information

Is there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data)

Is there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data) Is there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data) (Angiolite BTK DES, IVascular) P. Goverde MD, K. Taeymans MD, K. Lauwers MD Vascular Clinic ZNA Antwerp,Belgium

More information

Distal By-Pass procedures can reduce limb loss

Distal By-Pass procedures can reduce limb loss Conventional treatment of the diabetic foot Distal By-Pass procedures can reduce limb loss Dr. Nikolaos Melas, PhD Vascular and Endovascular Surgeon Military Doctor Associate in 1st department of Surgery,

More information

Clinical Approach to CLI and Related Diagnostics: What You Need to Know

Clinical Approach to CLI and Related Diagnostics: What You Need to Know Clinical Approach to CLI and Related Diagnostics: What You Need to Know Ido Weinberg, MD Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital None Disclosures Critical

More information

PUT YOUR BEST FOOT FORWARD

PUT YOUR BEST FOOT FORWARD PUT YOUR BEST FOOT FORWARD Bala Ramanan, MBBS 1 st year vascular surgery fellow Introduction The epidemic of diabetes and ageing of our population ensures critical limb ischemia will continue to grow.

More information

Nurse and Technician Forum Part II Critical Limb Ischemia: Optimal care, an interdisciplinary challenge

Nurse and Technician Forum Part II Critical Limb Ischemia: Optimal care, an interdisciplinary challenge L E I P Z I G I N T E R V E N T I O N A L C O U R S E 2017 Nurse and Technician Forum Part II Critical Limb Ischemia: Optimal care, an interdisciplinary challenge Markus Haumer Landesklinikum Baden-Mödling

More information

Vascular screening in diabetic patients: how aggressive should we be and when to intervene?

Vascular screening in diabetic patients: how aggressive should we be and when to intervene? Vascular screening in diabetic patients: how aggressive should we be and when to intervene? Roberto Ferraresi Peripheral Interventional Unit Bergamo Italy Disclosure Speaker name: ROBERTO FERRARESI X X

More information

The relation of 2D perfusion angiography after BTK intervention and wound healing in patient with CLI - Single center prospective study -

The relation of 2D perfusion angiography after BTK intervention and wound healing in patient with CLI - Single center prospective study - The relation of 2D perfusion angiography after BTK intervention and wound healing in patient with CLI - Single center prospective study - Shinya Sasaki, MD. Saka General Hospital Miyagi, JAPAN Disclosure

More information

Disclosures. TASC, AHA, SVS: What s Happening with the Guidelines? How Are They Relevant? Purpose of Practice Guidelines

Disclosures. TASC, AHA, SVS: What s Happening with the Guidelines? How Are They Relevant? Purpose of Practice Guidelines TASC, AHA, SVS: What s Happening with the Guidelines? How Are They Relevant? Michael S. Conte MD, FACS Division of Vascular and Endovascular Surgery Co-Director, Heart and Vascular Center UCSF Medical

More information

WHO YOU GONNA CALL? CLOT-BUSTERS!

WHO YOU GONNA CALL? CLOT-BUSTERS! WHO YOU GONNA CALL? CLOT-BUSTERS! Jayer Chung MD, MSc Assistant Professor Division of Vascular Surgery and Endovascular Therapy Michael E DeBakey Department of Surgery Baylor College of Medicine Annual

More information

Garland Green, MD Interventional Cardiologist. Impact of PAD: Prevalence, Risk Factors, Testing, and Medical Management

Garland Green, MD Interventional Cardiologist. Impact of PAD: Prevalence, Risk Factors, Testing, and Medical Management Garland Green, MD Interventional Cardiologist Impact of PAD: Prevalence, Risk Factors, Testing, and Medical Management Peripheral Arterial Disease Affects over 8 million Americans Affects 12% of the general

More information

Transmetatarsal amputation in an at-risk diabetic population: a retrospective study

Transmetatarsal amputation in an at-risk diabetic population: a retrospective study The Journal of Diabetic Foot Complications Transmetatarsal amputation in an at-risk diabetic population: a retrospective study Authors: Merribeth Bruntz, DPM, MS* 1,2, Heather Young, MD 3,4, Robert W.

More information

Larry Diaz, MD, FSCAI Mehdi H. Shishehbor, DO, FSCAI

Larry Diaz, MD, FSCAI Mehdi H. Shishehbor, DO, FSCAI PAD Diagnosis Larry Diaz, MD, FSCAI Metro Health / University of Michigan Health, Wyoming, MI Mehdi H. Shishehbor, DO, FSCAI University Hospitals Harrington Heart & Vascular Institute, Cleveland, OH PAD:

More information

Treatment Strategies For Patients with Peripheral Artery Disease

Treatment Strategies For Patients with Peripheral Artery Disease Treatment Strategies For Patients with Peripheral Artery Disease Presented by Schuyler Jones, MD Duke University Medical Center & Duke Clinical Research Institute AHRQ Comparative Effectiveness Review

More information

DCB in my practice: How the evidence influences my strategy. Yang-Jin Park

DCB in my practice: How the evidence influences my strategy. Yang-Jin Park DCB in my practice: How the evidence influences my strategy Yang-Jin Park Associate Professor Division of Vascular Surgery, Department of Surgery Samsung Medical Center Sungkyunkwan University School of

More information

Due to Perimed s commitment to continuous improvement of our products, all specifications are subject to change without notice.

Due to Perimed s commitment to continuous improvement of our products, all specifications are subject to change without notice. A summary Disclaimer The information contained in this document is intended to provide general information only. It is not intended to be, nor does it constitute, medical advice. Under no circumstances

More information

When and how to use distal protection devices for lower extremity revascularization. Peter A. Schneider, MD Kaiser Foundation Hospital, Honolulu

When and how to use distal protection devices for lower extremity revascularization. Peter A. Schneider, MD Kaiser Foundation Hospital, Honolulu When and how to use distal protection devices for lower extremity revascularization Peter A. Schneider, MD Kaiser Foundation Hospital, Honolulu Disclosure Peter A. Schneider Potential conflicts of interest

More information

Resident Teaching Conference 3/12/2010

Resident Teaching Conference 3/12/2010 Resident Teaching Conference 3/12/2010 Goals Definition and Classification of Acute Limb Ischemia Clinical Assessment of the Vascular Patient History and Physical Diagnostic Modalities Management of Acute

More information

Lower Extremity Revascularization D oes Anesthesia Matter. Onaona Gurney PGY 4

Lower Extremity Revascularization D oes Anesthesia Matter. Onaona Gurney PGY 4 Lower Extremity Revascularization D oes Anesthesia Matter Onaona Gurney PGY 4 Case Presentation 89yoM PMH of HTN, DM, HLD, BPH presented to podiatry with abscess to R great toe 5 weeks prior Drained by

More information

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Dr. Sven Bräunlich Department of Angiology University-Hospital Leipzig, Germany Disclosure Speaker

More information

The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan

The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan COI disclosure Disclosure Speaker name: Taku Kato... I have the

More information

Guidelines for Management of Peripheral Arterial Disease

Guidelines for Management of Peripheral Arterial Disease Guidelines for Management of Peripheral Arterial Disease Subhash Banerjee, MD, FACC, FSCAI Professor of Medicine, Univ. of Texas Southwestern Medical Center Chief, Division of Cardiology, VA North Texas

More information

Access strategy for chronic total occlusions (CTOs) is crucial

Access strategy for chronic total occlusions (CTOs) is crucial Learn How Access Strategy Impacts Complex CTO Crossing Arthur C. Lee, MD The Cardiac & Vascular Institute, Gainesville, Florida VASCULAR DISEASE MANAGEMENT 2018;15(3):E19-E23. Key words: chronic total

More information